October 19th-22nd, 2015 | San Diego, CA

Speakers

Expand/Collapse

Tinya Abrams
Research Investigator
Novartis

Todd Allen
Director, Commercial Manufacturing
Seattle Genetics

Firelli Alonso-Caplen
Senior Director
Pfizer

Post Conference Workshops
Afternoon Session

October 22nd, 2015

13:00 – 17:00 | Workshop G: Continued

Post Conference Workshops
Morning Session

October 22nd, 2015

09:00 – 12:00 | Workshop G: ADC Outsourcing, Technology Transfer & CMO-Client Relationships

Meg Baker
Registered Patent Agent
Independent Consultant

Pre Conference Workshops
Morning Session

October 19th, 2015

09:00 – 12:00 | Workshop C: Entering the Crowded IP ADC Technology Landscape & Seeking Protections for New Products

Alain Beck
Senior Director, Antibody Physico-Chemistry
Pierre Fabre

Day Two

Wednesday October 21st, 2015

09:00 – | A Global Overview of Analytical Requirements & New Techniques for ADC Characterization

Alison Betts
Associate Research Fellow
Pfizer

Post Conference Workshops
Morning Session

October 22nd, 2015

09:00 – 12:00 | Workshop E: Utilizing PK/PD Modeling & Simulation to Create a Translational Framework for Development of Better ADCs

Mike Bienkowski
Manager, Process & Analytical Development
SAFC

Day Two

Wednesday October 21st, 2015

07:00 – | Breakfast Briefing: What’s in Your Toolbox? Choosing the Right Analytical Methods & Instrumentation for Defining In-Process Controls & Characterizing Your ADC

Berthold Boedeker
Chief Scientist
Bayer

David Bramhill
Consultant
BBC LLC

Pre Conference Workshops
Afternoon Session

October 19th, 2015

13:00 – 16:00 | Workshop B: Selection of the Optimal Antibody or Scaffold Format to Deliver Potent Warheads

Esther Breij
Assistant Director
Genmab

Jeiwook Chae
CBO
LegoChem

Cindy Choy
Postdoctoral Researcher
WSU

Cecile Combeau
Project Director
Sanofi

Anu Connor
Senior Reseacrh Investigator
Novartis

Jon Crate
CTO
FAI Testing Services

Post Conference Workshops
Afternoon Session

October 22nd, 2015

13:00 – 17:00 | Workshop G: Continued

Post Conference Workshops
Morning Session

October 22nd, 2015

09:00 – 12:00 | Workshop G: ADC Outsourcing, Technology Transfer & CMO-Client Relationships

Paul Davis
CEO
Quanta BioDesign

Floris van Delft
CSO
Synaffix

Jonathan Drachman
CMO
Seattle Genetics

Scott Dylla
CSO
Stemcentrx

Day One

Tuesday October 20th, 2015

08:30 – | New Horizons: ADC Paradigms Challenged

John Gebler
Director, Biopharma Business Development
Waters

Day Two

Wednesday October 21st, 2015

09:30 – | Routine Use of Liquid Chromatography with Mass Spectrometry (LC/MS) to Determine Key Quality Attributes

Hans Peter Gerber
VP, Bioconjugates
Pfizer

Day One

Tuesday October 20th, 2015

08:00 – | Keynote: Evolutionary Improvements in Calicheamicin-ADC Design

Antony Godwin
VP, Chemistry
PolyTherics

David Goldenberg
CSO
Immunomedics

Maria Elena Guadagno
Director
BSP Pharmaceuticals

Ed Ha
Scientist
Solstice Biologics

Pre Conference Workshops
Afternoon Session

October 19th, 2015

13:00 – 16:00 | Workshop D: Assess Payload Selection Options & Design the Most Efficacious Drug Conjugates

Urs Hagemann
Project Manager
Bayer

Kim Hejnaes
Partner
Invest4biotech

Post Conference Workshops
Afternoon Session

October 22nd, 2015

13:00 – 17:00 | Workshop G: Continued

Post Conference Workshops
Morning Session

October 22nd, 2015

09:00 – 12:00 | Workshop G: ADC Outsourcing, Technology Transfer & CMO-Client Relationships

Mary Jane Hinrichs
Senior Toxicologist
MedImmune

Robert Hollingsworth
Senior Director
MedImmune

Andreas Karau
Director, Strategic Innovation Management
Evonik

Thomas Keating
Director, Biochemistry
ImmunoGen

Leo Kirkovsky
Director
Pfizer

Post Conference Workshops
Afternoon Session

October 22nd, 2015

13:00 – 16:00 | Workshop F: Preclinical & Clinical Assay Development for Improving ADC Understanding

Norbert Koper
VP, Clinical
Synthon

Mary Krause
Research Investigator
BMS

John Lambert
Distinguished Research Fellow
ImmunoGen

Day Two

Wednesday October 21st, 2015

16:00 – | Designing an ADC with a DNA-alkylating Payload: A Focus on Therapeutic Index

Byoung-Chul Lee
Scientist
Genentech

Peter Lemaire
Analytical Team Lead
BMS

Jens Lohrmann
Technical Project Leader
Novartis

Timothy Lowinger
CSO
Mersana

Day Two

Wednesday October 21st, 2015

15:30 – | Fleximer ADCs: Advancing the Platforms Towards the Clinic

Lisa McDermott
Principal Scientist, Process & Analytical Development
SAFC

Day Two

Wednesday October 21st, 2015

07:00 – | Breakfast Briefing: What’s in Your Toolbox? Choosing the Right Analytical Methods & Instrumentation for Defining In-Process Controls & Characterizing Your ADC

Colin McKee
Head, Technical Services
ADC Biotechnology

Day Two

Wednesday October 21st, 2015

10:00 – | Lock-Release – A New Paradigm for ADC Development & Manufacturing

Brian Mendelsohn
Senior Scientist
Agensys

David Miao
SVP
Sorrento Therapeutics

Day One

Tuesday October 20th, 2015

16:00 – | Preclinical Development of Superior ADCs Incorporating Novel Linker & Warhead Designs

Neil Mody
Scientist I
MedImmune

Vincent Monchois
Director, Strategic Projects
Novasep

Miriam Monge
Director, Integrated Solutions & Process Development Team
Sartorius

Charles Morris
CDO
ImmunoGen

Morten Munk
Senior Technology Partner
NNE Pharmaplan

Post Conference Workshops
Afternoon Session

October 22nd, 2015

13:00 – 17:00 | Workshop G: Continued

Post Conference Workshops
Morning Session

October 22nd, 2015

09:00 – 12:00 | Workshop G: ADC Outsourcing, Technology Transfer & CMO-Client Relationships

Andreas Pahl
CSO
Heidelberg Pharma

Day One

Tuesday October 20th, 2015

16:30 – | Developing Potent ADC Payloads with Non-DNA Targeting Mechanisms of Action

Amar Prashad
Principal Scientist
Pfizer

Gillian Payne
Senior Director
ImmunoGen

Paul Polakis
Director
Genentech

Day Two

Wednesday October 21st, 2015

16:30 – | Lessons Learned from ADCs so Far

David Rabuka
Global Head of R&D, Chemical Biology
Catalent

Vangipuram Rangan
Senior Director
BMS

Chetana Rao
Associate Director
BMS

Day One

Tuesday October 20th, 2015

07:45 – | Chair’s Opening Remarks

Day Two

Wednesday October 21st, 2015

08:45 – | Chair’s Opening Remarks

Alan Rigby
VP
Eli Lilly

Dan Rock
Scientific Director
Amgen

Jack Sadowsky
Scientist
Genentech

Pre Conference Workshops
Morning Session

October 19th, 2015

09:00 – 12:00 | Workshop A: Challenges, Opportunities & New Approaches for the Synthesis of Well-defined ADCs

Wendy Saffell-Clemmer
Director, Research
Baxter

David Satijn
Associate Director
Genmab

Peter Senter
VP, Chemistry
Seattle Genetics

Day One

Tuesday October 20th, 2015

17:00 – | Contextualizing Chemical Optimization in the Quest for Next Generation ADCs

Anette Sommer
Principal Scientist
Bayer

Pavel Strop
Associate Research Fellow
Pfizer

Jon Terrett
Senior Director, Oncology
CytomX

Lawrence Thomas
Senior Director, Preclinical Development
Celldex Therapeutics

Richard Vandlen
Staff Scientist
Genentech

Pre Conference Workshops
Morning Session

October 19th, 2015

09:00 – 12:00 | Workshop A: Challenges, Opportunities & New Approaches for the Synthesis of Well-defined ADCs

Andreas Weiler
Head, Emerging Technologies
Lonza

Mark Wright
Site Lead
Piramal